Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples